세계의 단위 용량 포장 시장 : 형태별, 소재 유형별, 제품 유형별, 최종 이용 산업별, 지역별 예측(-2029년)

The unit dose packaging market is projected to grow from USD 29.1 Billion in 2024 to USD 43.8 Billion by 2029, at a CAGR of 8.5% during the forecast period. The rising demand for blister packaging is significantly driving the growth of the unit dose packaging market due to its key advantages in ensuring medication safety, accuracy, and convenience. Blister packaging, which encloses individual doses in plastic and foil compartments, is widely used in the pharmaceutical industry for its ability to protect medications from moisture and light, preserving their potency. Medications such as birth control pills and over-the-counter pain relievers are often packaged in blister packs, which help patients easily track doses and adhere to their medication schedules. This method not only improves patient compliance by clearly separating and labeling each dose but also reduces medication errors. The convenience of blister packaging makes it ideal for individuals with busy lifestyles, further boosting its popularity. The healthcare sector's emphasis on patient safety and adherence, along with the practical benefits of blister packaging, continues to drive its adoption across various industries.

"By Form, solid is the second largest market share for unit dose packaging during forecast period."

Solid unit dose packaging accounts for a substantial share, estimated at 30-35%. This packaging format is widely used in pharmaceuticals, where blister packs for tablets and capsules are common. Products such as ibuprofen, antihistamines, and multivitamins are frequently packaged in this way to ensure precise dosing and protection from environmental factors. In the nutraceutical sector, solid unit dose packaging is employed for vitamins and dietary supplements like Omega-3 capsules, providing convenience and accurate dosing. Cosmetics also use solid unit dose formats for items such as single-use capsules containing skincare treatments and face masks. The growth of solid unit dose packaging is largely driven by its extensive application in the pharmaceutical industry.

"By Material Type, plastic account for largest market share for unit dose packaging during forecast period."

Plastic, a synthetic material made by linking monomers in various configurations, offers unique properties like flexibility, durability, and resistance to degradation. In the unit dose packaging industry, plastics such as polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC) are valued for their effective barriers against moisture, light, gases, and contaminants. These materials are crucial in healthcare and pharmaceuticals due to their precise dosing capabilities, tamper-evident seals, and easy-open features, ensuring secure and user-friendly medication delivery. Plastic packaging is cost-effective, reducing waste and meeting stringent sterility and regulatory standards, thus maintaining medication safety and efficacy. Compared to glass and aluminum, plastics are preferred for their lightweight nature, impact resistance, and design flexibility, accommodating specialized forms and sizes for various applications.

"By Product Type, blister pack account for largest share during forecast period."

Blister packs consist of a thermoformed plastic cavity and a flexible top, designed to protect contents from moisture, gases, light, and physical damage, thereby preserving their integrity and extending shelf life. They securely house individual doses of medications, vitamins, supplements, and other products. To address sustainability concerns, modern blister packs use eco-friendly materials and efficient designs to minimize environmental impact while meeting market needs in pharmaceuticals, nutraceuticals, and medical devices. Blister packs contribute to packaging efficiency by enhancing product protection, ensuring precise dosing, and increasing safety. Leading companies such as Amcor plc, Constantia Flexibles, and West Pharmaceutical Services are incorporating smart technologies like RFID (Radio Frequency Identification) and NFC (Near Field Communication) into blister packs to improve tracking, authentication, and real-time monitoring. Additionally, Klockner Pentaplast offers advanced films with high clarity, autoclavable laminate, and robust barriers against moisture and package leaching. These films are ideal for hot-fill liquids and new dosage forms, providing customizable moisture protection, high heat stability, quick release, and excellent odor and flavor retention.

"By End-Use Industry, Pharmaceutical End-use Industry Segment Accounted For largest share during forecast period."

Unit dose packaging is crucial in the pharmaceutical industry for distributing precise doses of medications, vitamins, oral liquids, and injectables. It ensures that each dose is securely contained in a sealed package, such as vials, ampoules, or blister packs. Technologies like Blow-Fill-Seal (BFS) streamline the sterile packaging process, minimizing contamination risks and enhancing product safety. The trend towards prefilled syringes and auto-injectors provides accurate dosing and improved patient compliance with added safety features. Innovations in sensors and indicators monitor environmental conditions to maintain medication efficacy. The shift towards sustainable materials and optimized packaging sizes highlights the industry's commitment to reducing environmental impact while enhancing patient safety and dosing accuracy.

"North America is accounted larget market for Unit dose packaging in 2023."

The North America region is accounted larget in the unit dose packaging market. This growth encompasses countries like US, Canada, and Mexico.

The unit dose packaging market in North America is being propelled by various factors. In North America, the pharmaceutical industry heavily relies on unit dose packaging for its precision, patient compliance, and protection against contamination and tampering. This demand is driven by a focus on patient-centric solutions, the need for accurate dosing to reduce errors, and the convenience of use. The aging population and high prevalence of chronic diseases further boost the need for pharmaceuticals and healthcare services. According to pharma association, in 2023, the industry invested around USD 90 billion in R&D, reflecting its growth. Stringent regulations by the FDA and Health Canada ensure compliance with safety and quality standards, influencing packaging choices. Despite significant growth, challenges such as increased competition, innovation, and environmental regulations pose constraints to the market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the unit dose packaging market.

• By Company Type: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
• By Designation: C Level: 35%, Director Level: 30%, and Others: 35%
• By Region: North America: 25%, Europe: 20%, APAC: 45%, Middle East & Africa: 5%, and South America: 5%

Companies Covered: The global unit dose packaging market comprises major manufacturers, such as Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klockner Pentaplast (UK), among others.

Research Coverage

The market study covers the unit dose packaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on form, material type, product type, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the unit dose packaging market.

Key Benefits of Buying the Report

The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall unit dose packaging market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Thriving Pharmaceutical Sector and surge in healthcare expenditure, Rising demand for blister packaging, and Consumer preference for convenience and portability driving demand for unit dose packaging), restraints (The setup and maintenance of unit dose packaging machines and Environmental concerns), opportunities (Increasing demand for primary pharmaceutical packaging and Market expansion in nutraceuticals and cosmetics) and challenges (Technological challenges in the unit dose packaging market and High initial investment).
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the unit dose packaging market
• Market Development: Comprehensive information about lucrative markets - the report analyses the unit dose packaging market across varied regions

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the unit dose packaging market

• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klockner Pentaplast (UK), among others in the unit dose packaging market. The report also helps stakeholders understand the pulse of the unit dose packaging market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 UNIT DOSE PACKAGING MARKET SEGMENTATION
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
  • 1.3.4 UNITS CONSIDERED
• 1.4 LIMITATIONS
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key primary participants
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of interviews with experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 FORECAST NUMBER CALCULATION
• 2.4 DATA TRIANGULATION
• 2.5 FACTOR ANALYSIS
• 2.6 ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS AND RISKS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN UNIT DOSE PACKAGING MARKET
• 4.2 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY AND COUNTRY
• 4.3 NORTH AMERICA UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE
• 4.4 NORTH AMERICA UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY
• 4.5 UNIT DOSE PACKAGING MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Thriving pharmaceutical sector and surge in healthcare expenditure
    • 5.2.1.2 Rising demand for blister packaging
    • 5.2.1.3 Consumer preference for convenience and portability
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Substantial capital investment required for setup and maintenance of unit dose packaging machines
    • 5.2.2.2 Environmental concerns
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing demand for primary pharmaceutical packaging
    • 5.2.3.2 Market expansion in nutraceuticals and cosmetics
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Technological challenges
    • 5.2.4.2 High initial investment

6 INDUSTRY TRENDS

• 6.1 PORTER'S FIVE FORCES ANALYSIS
  • 6.1.1 THREAT OF NEW ENTRANTS
  • 6.1.2 THREAT OF SUBSTITUTES
  • 6.1.3 BARGAINING POWER OF SUPPLIERS
  • 6.1.4 BARGAINING POWER OF BUYERS
  • 6.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 6.2 VALUE CHAIN ANALYSIS
• 6.3 TRADE ANALYSIS
  • 6.3.1 EXPORT SCENARIO
  • 6.3.2 IMPORT SCENARIO
• 6.4 IMPACT OF GEN AI ON UNIT DOSE PACKAGING
  • 6.4.1 INTEGRATING AI IN UNIT DOSE PACKAGING
  • 6.4.2 BEST PRACTICES TO LEVERAGE AI FOR UNIT DOSE PACKAGING MARKET
  • 6.4.3 USE CASES OF GENERATIVE AI IN UNIT DOSE PACKAGING MARKET
    • 6.4.3.1 Future of generative AI in unit dose packaging market
• 6.5 MACROECONOMIC INDICATORS
  • 6.5.1 GLOBAL GDP OUTLOOK
• 6.6 TECHNOLOGY ANALYSIS
  • 6.6.1 KEY TECHNOLOGIES
    • 6.6.1.1 Blister packaging
    • 6.6.1.2 Strip packaging
    • 6.6.1.3 Blow-Fill-Seal
  • 6.6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.6.2.1 Smart packaging
    • 6.6.2.2 Barrier and coating
• 6.7 TARIFF AND REGULATORY LANDSCAPE
  • 6.7.1 TARIFF RELATED TO UNIT DOSE PACKAGING MARKET
  • 6.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 6.8 CASE STUDY ANALYSIS
• 6.9 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 6.10 KEY CONFERENCES & EVENTS IN 2024-2025
• 6.11 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 6.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 6.11.2 BUYING CRITERIA
• 6.12 ECOSYSTEM ANALYSIS
• 6.13 PATENT ANALYSIS
  • 6.13.1 INTRODUCTION
  • 6.13.2 METHODOLOGY
• 6.14 PRICING ANALYSIS
  • 6.14.1 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING, BY REGION
  • 6.14.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL TYPE
  • 6.14.3 INVESTMENT AND FUNDING SCENARIO

7 UNIT DOSE PACKAGING MARKET, BY FORM

• 7.1 INTRODUCTION
• 7.2 LIQUID
• 7.3 SOLID
• 7.4 POWDER
• 7.5 GEL

8 UNIT DOSE PACKAGING MARKET, BY MATERIAL TYPE

• 8.1 INTRODUCTION
• 8.2 PLASTIC
  • 8.2.1 POLYVINYL CHLORIDE
  • 8.2.2 POLYETHYLENE
  • 8.2.3 POLYPROPYLENE
  • 8.2.4 POLYETHYLENE TEREPHTHALATE
  • 8.2.5 OTHER PLASTIC FILMS
• 8.3 GLASS
• 8.4 PAPER & PAPERBOARD
• 8.5 ALUMINUM
• 8.6 OTHER MATERIAL TYPES

9 UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE

• 9.1 INTRODUCTION
• 9.2 BLISTER PACKS
  • 9.2.1 ENSURE DRUG DOSING ACCURACY AND INCREASED SAFETY
• 9.3 SACHETS & STRIP PACKS
  • 9.3.1 MAINTAIN PRODUCT FRESHNESS AND QUALITY
• 9.4 AMPOULES & VIALS
  • 9.4.1 USED FOR STORING AND DISPENSING LIQUID PHARMACEUTICALS
• 9.5 OTHER PRODUCT TYPES

10 UNIT DOSE PACKAGING, BY END-USE INDUSTRY

• 10.1 INTRODUCTION
• 10.2 PHARMACEUTICALS
  • 10.2.1 INCREASED DEMAND FOR PREFILLED SYRINGES AND AUTO-INJECTORS
• 10.3 COSMETICS & PERSONAL CARE
  • 10.3.1 EXTENDING SHELF LIFE OF BEAUTY PRODUCTS
• 10.4 NUTRACEUTICALS
  • 10.4.1 ADMINISTRATION OF PRECISE DOSAGE AND CONSUMER COMPLIANCE
• 10.5 OTHER END-USE INDUSTRIES

11 UNIT DOSE PACKAGING MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 ASIA PACIFIC
  • 11.2.1 CHINA
    • 11.2.1.1 Rising investments in biologics and biosimilar drug research to drive market
  • 11.2.2 INDIA
    • 11.2.2.1 Large domestic consumption and export of generic drugs to drive market
  • 11.2.3 JAPAN
    • 11.2.3.1 Surge in aging population to drive demand for medications
  • 11.2.4 SOUTH KOREA
    • 11.2.4.1 Growth of cosmetic & personal care industries to drive market
  • 11.2.5 REST OF ASIA PACIFIC
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Advanced healthcare infrastructure and emphasis on patient-centric care to drive market
  • 11.3.2 FRANCE
    • 11.3.2.1 Surge in demand for generic drugs to drive market
  • 11.3.3 ITALY
    • 11.3.3.1 Growing exports of pharmaceutical products to boost market
  • 11.3.4 UK
    • 11.3.4.1 Innovations in drug manufacturing to drive market
  • 11.3.5 SPAIN
    • 11.3.5.1 Growth of cosmetic & personal care industry to drive market
  • 11.3.6 REST OF EUROPE
• 11.4 NORTH AMERICA
  • 11.4.1 US
    • 11.4.1.1 Increasing demand for RFID integration and smart packaging to drive market
  • 11.4.2 CANADA
    • 11.4.2.1 Rising demand for precise packaging to drive market
  • 11.4.3 MEXICO
    • 11.4.3.1 Technological advancements and packaging innovations to boost market
• 11.5 SOUTH AMERICA
  • 11.5.1 BRAZIL
    • 11.5.1.1 Increased healthcare awareness and substantial investment to drive market
  • 11.5.2 ARGENTINA
    • 11.5.2.1 Innovations in packaging to drive market
  • 11.5.3 REST OF SOUTH AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 GCC COUNTRIES
    • 11.6.1.1 Saudi Arabia
      • 11.6.1.1.1 Saudi Vision 2030 to boost demand for advanced medical packaging solutions
    • 11.6.1.2 UAE
      • 11.6.1.2.1 Increasing demand for dietary supplements and functional foods to drive market
    • 11.6.1.3 Rest of GCC countries
  • 11.6.2 SOUTH AFRICA
    • 11.6.2.1 Government initiatives upholding safety and efficacy standards to boost market
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 12.3 REVENUE ANALYSIS
• 12.4 MARKET SHARE ANALYSIS
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 PRODUCT/BRAND COMPARISON ANALYSIS
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Form footprint
    • 12.7.5.3 Material type footprint
    • 12.7.5.4 Product type footprint
    • 12.7.5.5 End-use industry footprint
    • 12.7.5.6 Region footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 12.9 COMPETITIVE SCENARIO AND TRENDS
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 PFIZER INC.
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 AMCOR PLC
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Expansion
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 CORNING INCORPORATED
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches
      • 13.1.3.3.2 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 WEST PHARMACEUTICAL SERVICES
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Expansion
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 STEVANATO GROUP
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
      • 13.1.5.3.2 Deals
      • 13.1.5.3.3 Expansion
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 GERRESHEIMER AG
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches
      • 13.1.6.3.2 Deals
      • 13.1.6.3.3 Expansion
    • 13.1.6.4 MnM view
  • 13.1.7 SCHOTT
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches
      • 13.1.7.3.2 Deals
      • 13.1.7.3.3 Expansion
    • 13.1.7.4 MnM view
  • 13.1.8 NIPRO
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
    • 13.1.8.4 MnM view
  • 13.1.9 CONSTANTIA FLEXIBLES
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Deals
      • 13.1.9.3.2 Expansion
    • 13.1.9.4 MnM view
  • 13.1.10 KLOCKNER PENTAPLAST
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Expansion
    • 13.1.10.4 MnM view
• 13.2 OTHER PLAYERS
  • 13.2.1 SONIC PACKAGING INDUSTRIES INC.
  • 13.2.2 SHARP SERVICES, LLC
  • 13.2.3 TEKNI-PLEX, INC.
  • 13.2.4 THERMO-PAK CO. INC.
  • 13.2.5 APHENA PHARMA SOLUTIONS
  • 13.2.6 PACIFIC VIAL MANUFACTURING INC.
  • 13.2.7 HEALTH CARE LOGISTICS, INC.
  • 13.2.8 ULTRA SEAL CORPORATION
  • 13.2.9 SAFECORE HEALTH
  • 13.2.10 UNIT PACK
  • 13.2.11 JONES HEALTHCARE GROUP
  • 13.2.12 ROPACK INC.
  • 13.2.13 RX SYSTEMS, INC.
  • 13.2.14 JAMES ALEXANDER CORPORATION
  • 13.2.15 PHARMACY AUTOMATION SUPPLIES

14 ADJACENT & RELATED MARKETS

• 14.1 INTRODUCTION
• 14.2 LIMITATIONS
  • 14.2.1 PHARMACEUTICAL PACKAGING MARKET
    • 14.2.1.1 Market definition
    • 14.2.1.2 Pharmaceutical packaging market, by packaging type
    • 14.2.1.3 Pharmaceutical packaging market, by raw material
    • 14.2.1.4 Pharmaceutical packaging market, by drug delivery
    • 14.2.1.5 Pharmaceutical packaging market, by type
    • 14.2.1.6 Pharmaceutical packaging market, by region
  • 14.2.2 NUTRACEUTICAL PACKAGING MARKET
    • 14.2.2.1 Market definition
    • 14.2.2.2 Nutraceutical packaging market, by product form
    • 14.2.2.3 Nutraceutical packaging market, by product type
    • 14.2.2.4 Nutraceutical packaging market, by packaging type
    • 14.2.2.5 Nutraceutical packaging market, by material
    • 14.2.2.6 Nutraceutical packaging market, by ingredient
    • 14.2.2.7 Nutraceutical packaging market, by region

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 CUSTOMIZATION OPTIONS
• 15.3 RELATED REPORTS
• 15.4 AUTHOR DETAILS